Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 22, 2007
Human Molecular Genetics 2007 16(17):2021-2030; doi:10.1093/hmg/ddm150
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
16/17/2021    most recent
ddm150v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Thys, M.
Right arrow Articles by Van Camp, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thys, M.
Right arrow Articles by Van Camp, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The coding polymorphism T263I in TGF-ß1 is associated with otosclerosis in two independent populations

Melissa Thys1, Isabelle Schrauwen1, Kathleen Vanderstraeten1, Katrien Janssens1,{dagger}, Nele Dieltjens1, Kris Van Den Bogaert1,{ddagger}, Erik Fransen1, Wenjie Chen2, Megan Ealy2, Mireille Claustres3, Cor R.W.J. Cremers4, Ingeborg Dhooge5, Frank Declau6, Jos Claes6, Paul Van de Heyning6, Robert Vincent7, Thomas Somers8, Erwin Offeciers8, Richard J.H. Smith2 and Guy Van Camp1,*

1 Department of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk (Antwerp), Belgium, 2 Molecular Otolaryngology Research Laboratories, Department of Otolaryngology, University of Iowa, 200 Hawkins Drive, Iowa City IA 52242, USA, 3 Laboratoire de Genetique Moleculaire et chromosomique CHU, IURC Montpellier, 641 avenue du Doyen Gaston Giraud, 34093 Montpellier Cedex 5, France, 4 Department of Otorhinolaryngology, University Medical Centre St Radboud, Philips van Leydenlaan 15, 6500 HB Nijmegen, The Netherlands, 5 Department of Otorhinolaryngology, University Hospital of Ghent, De Pintelaan 185, 9000 Ghent, Belgium, 6 Department of ORL, University Hospital of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium, 7 Jean Causse Ear Clinic, Traverse de Béziers, 34440 Colombiers, France and 8 University Department of Otolaryngology, St-Augustinus Hospital Antwerp, Oosterveldlaan 24, 2610 Antwerp, Belgium

* To whom correspondence should be addressed. Tel: +32 38202491; Fax: +32 38202566; Email: guy.vancamp{at}ua.ac.be

Received May 8, 2007; Accepted June 8, 2007

Otosclerosis is a progressive hearing loss characterized by an abnormal bone homeostasis of the otic capsule that leads to stapes fixation. Although its etiology remains unknown, otosclerosis can be considered a complex disease. Transforming growth factor-beta 1 (TGF-ß1) was chosen for a case–control association study, because of several non-genetic indications of involvement in otosclerosis. Single nucleotide polymorphism (SNP) analysis in a large Belgian–Dutch sample set gave significant results (P = 0.0044) for an amino acid changing SNP, T263I. Analysis of an independent French population replicated this association with SNP T263I (P = 0.00019). The results remained significant after multiple testing correction in both populations. Haplotype analysis and the results of an independent effect test using the weighted haplotype (WHAP) computer program in both populations were both compatible with SNP T263I being the only causal variant. The variant I263 is under-represented in otosclerosis patients and hence protective against the disease. Combining the data of both case–control groups for SNP T263I with a Mantel–Haenszel estimate of common odds ratios gave a very significant result (P = 9.2 x 10–6). Functional analysis of SNP T263I with a luciferase reporter assay showed that the protective variant I263 of TGF-ß1 is more active than the WT variant T263 (P = 1.6 x 10–6). On the basis of very low P-values, replication in an independent population and a functional effect of the protective variant, we conclude that TGF-ß1 influences the susceptibility for otosclerosis, and that the I263 variant is protective against the disease.

{dagger} Present address: European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, 69117 Heidelberg, Germany.

{ddagger} Present address: Stem Cell Institute Leuven (SCIL), Catholic University Leuven, Herestraat 49, 3000 Leuven, Belgium.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
X. Yuan, Z. Liao, Z. Liu, L.-E Wang, S. L. Tucker, L. Mao, X. S. Wang, M. Martel, R. Komaki, J. D. Cox, et al.
Single Nucleotide Polymorphism at rs1982073:T869C of the TGF{beta}1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy
J. Clin. Oncol., July 10, 2009; 27(20): 3370 - 3378.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.